Cargando…

Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness

Biotinidase was identified in secretome analysis of thyroid cancer cell lines using proteomics. The goal of the current study was to analyze the expression of biotinidase in thyroid cancer tissues and fine needle aspiration (FNA) samples to evaluate its diagnostic and prognostic potential in thyroid...

Descripción completa

Detalles Bibliográficos
Autores principales:	So, Anthony K.-C., Kaur, Jatinder, Kak, Ipshita, Assi, Jasmeet, MacMillan, Christina, Ralhan, Ranju, Walfish, Paul G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402459/ https://www.ncbi.nlm.nih.gov/pubmed/22911723 http://dx.doi.org/10.1371/journal.pone.0040956

Ejemplares similares

Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma
por: Kunavisarut, Tada, et al.
Publicado: (2012)

An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma
por: He, Helen C.-H., et al.
Publicado: (2012)

Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants
por: Chowdhury, Subrata, et al.
Publicado: (2016)

Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features
por: Fu, Guodong, et al.
Publicado: (2017)

EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
por: Ralhan, Ranju, et al.
Publicado: (2010)

Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas
por: Assi, Jasmeet, et al.
Publicado: (2015)

Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients
por: Srivastava, Gunjan, et al.
Publicado: (2014)

Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis
por: Somasundaram, Raj Thani, et al.
Publicado: (2016)

Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients
por: Kumar, Manish, et al.
Publicado: (2015)

Transglutaminase 2 Overexpression in Tumor Stroma Identifies Invasive Ductal Carcinomas of Breast at High Risk of Recurrence
por: Assi, Jasmeet, et al.
Publicado: (2013)

Programmed death-ligand 1 expression by digital image analysis advances thyroid cancer diagnosis among encapsulated follicular lesions
por: Hsieh, Anne M.-Y., et al.
Publicado: (2018)

Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers
por: Ralhan, Ranju, et al.
Publicado: (2010)

ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy
por: Fu, Guodong, et al.
Publicado: (2016)

Clinical Significance of Altered Expression of β-Catenin and E-Cadherin in Oral Dysplasia and Cancer: Potential Link with ALCAM Expression
por: Kaur, Jatinder, et al.
Publicado: (2013)

Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy
por: Srivastava, Gunjan, et al.
Publicado: (2015)

Management of anesthesia in biotinidase deficiency
por: Goktas, Ugur, et al.
Publicado: (2014)

Visual Loss in Biotinidase Deficiency
por: Venugopal, Nataraja P.
Publicado: (2020)

The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness
por: Sheikh-Ahmad, Mohammad, et al.
Publicado: (2023)

Auditory Neuropathy/Dyssynchrony in Biotinidase Deficiency
por: Talebi, Hossein, et al.
Publicado: (2016)

First microdeletion involving only the biotinidase gene that can cause biotinidase deficiency: A lesson for clinical practice
por: Wolf, Barry
Publicado: (2016)

Clinical significance of Phosphatidyl Inositol Synthase overexpression in oral cancer
por: Kaur, Jatinder, et al.
Publicado: (2010)

Comment on: Childhood optic atrophy in biotinidase deficiency
por: Venugopal, N, et al.
Publicado: (2016)

Biotinidase Deficiency: Prevalence, Impact And Management Strategies
por: Canda, Ebru, et al.
Publicado: (2020)

Is serum biotinidase enzyme activity a potential marker of perturbed glucose and lipid metabolism?
por: Forny, Patrick, et al.
Publicado: (2020)

The indices of body size and aggressiveness of papillary thyroid carcinoma
por: Kim, Ju-Yeon, et al.
Publicado: (2011)

Molecular Pathways Associated with Aggressiveness of Papillary Thyroid Cancer
por: Benvenga, Salvatore, et al.
Publicado: (2014)

Management of the Patient with Aggressive and Resistant Papillary Thyroid Carcinoma
por: Miftari, Rame, et al.
Publicado: (2016)

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas
por: Jin, Meihua, et al.
Publicado: (2021)

Aggressive Papillary Thyroid Carcinoma Presenting with Metastasis to the Pancreas
por: Warda, Firas, et al.
Publicado: (2022)

Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer
por: Chauhan, S S, et al.
Publicado: (2015)

Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer
por: Kumar, Manish, et al.
Publicado: (2015)

Biotinidase deficiency: A treatable cause of infantile seizures
por: Bhardwaj, Parveen, et al.
Publicado: (2010)

Genotypic and phenotypic correlations of biotinidase deficiency in the Chinese population
por: Hsu, Rai-Hseng, et al.
Publicado: (2019)

Congenital biotinidase deficiency – MRI findings in two cases
por: Ranjan, Rahul S, et al.
Publicado: (2019)

Comparison of Spectrophotometric and Fluorimetric Methods in Evaluation of Biotinidase Deficiency
por: Işeri-Erten, Sevgin Özlem, et al.
Publicado: (2016)

Biotinidase Deficiency in the Second Decade with Atypical Neuroimaging Findings
por: Gowda, Vykuntaraju K., et al.
Publicado: (2023)

LGR5 is associated with tumor aggressiveness in papillary thyroid cancer
por: Michelotti, Gregory, et al.
Publicado: (2015)

Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma
por: Teng, Huajing, et al.
Publicado: (2018)

Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis
por: Hasan, Raghibul, et al.
Publicado: (2014)

The Biotinidase Gene Variants Registry: A Paradigm Public Database
por: Procter, Melinda, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c9e15q01cvec3mk90humhepcoh